Page last updated: 2024-11-07

imidodiphosphonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

imidodiphosphonic acid: in combination with technetrium, a superior radiopharmaceutical for myocardial infarct imaging; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122874
CHEMBL ID265450
MeSH IDM0066555

Synonyms (15)

Synonym
2pn ,
imidodiphosphoric acid
27590-04-1
(phosphonoamino)phosphonic acid
CHEMBL265450
imidobisphosphate
FT-0695048
einecs 247-423-9
imidodiphosphonate
imidodiphosphonic acid
DTXSID00181989
imidodiphosphoric acid tetrasodium salt
iminodiphosphonic acid
bdbm50478336
Q27453169
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Type IV secretion-like conjugative transfer relaxase protein TraI Escherichia coli SMS-3-5Ki0.00240.00200.00270.0030AID328050; AID328051
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Type IV secretion-like conjugative transfer relaxase protein TraI Escherichia coli SMS-3-5Km0.29400.29400.29400.2940AID328052
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID233500The pKa value was measured at 31-P chemical shift changes due to protonation1993Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23
Protonation of phosphoramide mustard and other phosphoramides.
AID328060Selectivity ratio, ratio of EC50 for Escherichia coli JS10 to ratio of EC50 for inhibition of conjugate DNA transfer between Escherichia coli JS10 and Escherichia coli JS42007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328057Cytotoxicity against streptomycin-resistant F plasmid deficient Escherichia coli JS42007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328052Activity of Escherichia coli F plasmid TraI relaxase Y16F mutant assessed as oriT ssDNA cleavage2007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328053Inhibition of Escherichia coli F plasmid TraI relaxase Y16F mutant assessed as oriT ssDNA cleavage at 200 nM2007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328058Selectivity ratio, ratio of EC50 for Escherichia coli JS4 to EC50 for Escherichia coli JS102007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328051Inhibition of Escherichia coli F plasmid TraI relaxase Y16F mutant assessed as oriT ssDNA cleavage by uncompetitive inhibition assay2007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328056Cytotoxicity against tetracycline-resistant F plasmid positive Escherichia coli JS102007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328050Inhibition of Escherichia coli F plasmid TraI relaxase Y16F mutant assessed as oriT ssDNA cleavage by competitive inhibition assay2007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID233499The pKa value was measured at 17-O chemical shift changes due to protonation1993Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23
Protonation of phosphoramide mustard and other phosphoramides.
AID328061Selectivity ratio, ratio of EC50 for Escherichia coli JS4 to ratio of EC50 for inhibition of conjugate DNA transfer between Escherichia coli JS10 and Escherichia coli JS42007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328059Selectivity ratio, ratio of EC50 for inhibition of conjugate DNA transfer between Escherichia coli JS10 and Escherichia coli JS4 to EC50 for Escherichia coli JS102007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
AID328055Inhibition of conjugate DNA transfer between tetracycline-resistant F plasmid positive Escherichia coli JS10 to streptomycin-resistant F plasmid deficient Escherichia coli JS42007Proceedings of the National Academy of Sciences of the United States of America, Jul-24, Volume: 104, Issue:30
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (16.13)18.7374
1990's4 (12.90)18.2507
2000's11 (35.48)29.6817
2010's8 (25.81)24.3611
2020's3 (9.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.24 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]